Orlando FL 克罗恩病临床试验
17项针对 克罗恩病的研究正在 Orlando及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 距离 16 英里
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 距离 16 英里
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 距离 24 英里
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
招募中2 期
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 距离 16 英里
- 以及另外 1 项
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 距离 16 英里
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
招募中2 期
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 距离 16 英里
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 距离 16 英里
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
招募中
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
招募中观察性研究
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
招募中4 期
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
招募中2 期
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
招募中2 期
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 距离 16 英里
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Orlando
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Houston, TX17 项研究
- Atlanta, GA17 项研究
- Tyler, TX16 项研究
- San Diego, CA15 项研究
- San Antonio, TX15 项研究
- Los Angeles, CA15 项研究
- Philadelphia, PA13 项研究
Orlando的其他研究
- 非小细胞肺癌44 项研究
- 肥胖症31 项研究
- 转移性癌症29 项研究
- 超重27 项研究
- 阿尔茨海默病25 项研究
- 2型糖尿病24 项研究
- 癌症（所有类型）24 项研究
- 乳腺癌23 项研究
- 卵巢癌22 项研究
- 溃疡性结肠炎22 项研究
- 肺癌21 项研究
- 结直肠癌19 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。